EXOLENS
LIVE

Serial Number

99037289

Owner

Flagship Labs 103, Inc.

Attorney

Christina M. Licursi

Filing Date

Feb 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EXOLENS Trademark

Serial Number: 99037289

EXOLENS is a trademark filed by Flagship Labs 103, Inc. on February 11, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Flagship Labs 103, Inc. (3 trademarks)

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

February 11, 2025

Registration Date

Not Registered

Published for Opposition

November 11, 2025

Goods & Services

Pharmaceutical research and development; scientific and medical research and development in the field of computational biology, bioinformatics, genomics, biotechnology, diagnostics, and pharmaceuticals; temporary use of online, non-downloadable software for drug development, namely, software for cellular diagnostic and research systems and for cellular isolation and analysis; temporary use of online, non-downloadable software in the nature of a drug discovery platform, namely, software for cellular diagnostic and research systems and for cellular isolation and analysis; temporary use of online, non-downloadable software in the nature of a diagnostic platform used to isolate, fractionate, and interrogate cells as diagnostics; technical scientific consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and therapeutics; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, diagnostics, and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for cellular diagnostic and research services; platform as a service (PAAS) featuring computer software platforms for cellular isolation and analysis; platform as a service (PAAS) featuring computer software platforms to isolate, fractionate, and interrogate cells as diagnostics; all of the foregoing excluding optics and electro-optics and related services

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 21, 2026 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Mar 26, 2026 CHPB
ASSIGNED TO PETITION STAFF
Mar 23, 2026 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jan 26, 2026 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 11, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 10, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 6, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 20, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 11, 2025 MAFR
NEW APPLICATION ENTERED
Feb 11, 2025 NWAP